SHAREHOLDER ALERT: Weiss Law Investigates Metacrine, Inc.

NEW YORK, Nov. 23, 2022 /PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Metacrine, Inc. ("Metacrine" or the "Company") (NASDAQ: MTCR), in connection with the acquisition of the Company by Equillium, Inc. ("Equillium") (NASDAQ: EQ). Under the terms of the merger agreement, Equillium will issue stock valued at a 25% premium over the net cash delivered at closing, which is estimated to be approximately $26 million. 

Read more at prnewswire.com